Kangstem Biotech Co. Ltd - Asset Resilience Ratio

Latest as of September 2025: 51.78%

Kangstem Biotech Co. Ltd (217730) has an Asset Resilience Ratio of 51.78% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Kangstem Biotech Co. Ltd for a breakdown of total debt and financial obligations.

Liquid Assets

₩39.57 Billion

≈ $26.82 Million USD Cash + Short-term Investments

Total Assets

₩76.42 Billion

≈ $51.79 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Kangstem Biotech Co. Ltd's Asset Resilience Ratio has changed over time. See what is Kangstem Biotech Co. Ltd's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Kangstem Biotech Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 217730 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩39.57 Billion	51.78%
Total Liquid Assets	₩39.57 Billion	51.78%

Asset Resilience Insights

Very High Liquidity: Kangstem Biotech Co. Ltd maintains exceptional liquid asset reserves at 51.78% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Kangstem Biotech Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Kangstem Biotech Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Argen-X F:1AE	Biotechnology	25.67%
Tubize-Fin BR:TUB	Biotechnology	0.05%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
Dashenlin Pharm Grp Co Ltd SHG:603233	Biotechnology	0.02%
Staidson Beijing Biopharma SHE:300204	Biotechnology	7.93%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	41.25%
Ardelyx Inc NASDAQ:ARDX	Biotechnology	41.14%
Xiangxue Pharmaceutical SHE:300147	Biotechnology	0.05%

Annual Asset Resilience Ratio for Kangstem Biotech Co. Ltd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Kangstem Biotech Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	32.63%	₩18.27 Billion ≈ $12.38 Million	₩55.99 Billion ≈ $37.94 Million	-13.35pp
2023-12-31	45.98%	₩37.36 Billion ≈ $25.32 Million	₩81.25 Billion ≈ $55.06 Million	+0.47pp
2022-12-31	45.51%	₩36.68 Billion ≈ $24.86 Million	₩80.59 Billion ≈ $54.62 Million	-9.33pp
2021-12-31	54.84%	₩56.57 Billion ≈ $38.34 Million	₩103.15 Billion ≈ $69.90 Million	+9.23pp
2020-12-31	45.61%	₩37.63 Billion ≈ $25.50 Million	₩82.51 Billion ≈ $55.91 Million	+32.88pp
2019-12-31	12.73%	₩14.47 Billion ≈ $9.81 Million	₩113.64 Billion ≈ $77.01 Million	-2.52pp
2018-12-31	15.25%	₩11.16 Billion ≈ $7.56 Million	₩73.19 Billion ≈ $49.60 Million	-8.51pp
2017-12-31	23.76%	₩10.91 Billion ≈ $7.39 Million	₩45.91 Billion ≈ $31.12 Million	-25.37pp
2016-12-31	49.13%	₩23.31 Billion ≈ $15.80 Million	₩47.44 Billion ≈ $32.15 Million	--

pp = percentage points

About Kangstem Biotech Co. Ltd

KQ:217730 Korea Biotechnology

Market Cap

$254.64 Million

₩375.75 Billion KRW

Market Cap Rank

#15618 Global

#603 in Korea

Share Price

₩3995.00

Change (1 day)

-1.11%

52-Week Range

₩1171.00 - ₩4615.00

All Time High

₩18836.30